Document is current

Any future updates will be listed below

Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study

Crossref DOI link: https://doi.org/10.1007/s13318-015-0316-z

Published Online: 2016-01-21

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark